You visit the doctor because you think there is a problem. The doctor suspects it may be an infection but she’s not sure. A blood sample is taken and sent to the laboratory where three to five tests are run on it. Your blood does not show a positive reading for any of the tests conducted. You still don’t know what’s wrong.  Does this sound familiar?

Enter a pioneering piece of technology called the Biochip. This health testing platform, from global diagnostics company Randox, and on show at this year’s Goodwood Festival of Speed, can currently run 49 different tests simultaneously – making sure you get the right diagnosis as fast as possible.

Current and futuristic developments in this critical strand of medicine, involving detailed analysis of blood to identify both current and future health risks, are appearing as part of the festival’s Future Lab project.  Those visiting Future Lab will learn how technology can be utilised to improve the speed and accuracy of health diagnoses across the world.

With further plans to expand and enhance the Biochip even further – with capabilities to run over 1024 tests on a single blood sample – this technology is set to revolutionise the future of healthcare.

Randox Founder and Managing Director, Dr Peter FitzGerald, commented;

“For years we’ve been working behind-the-scenes with hospitals and laboratory professionals and, until now, our contribution to improving healthcare would not have been evident to the general public. But we know now that it’s time for us to come out – our technologies have the potential to transform healthcare around the world, and that matters to everyone.  

“More sensitive, comprehensive and accurate technologies hold the promise of much earlier and effective diagnosis, often before symptoms appear – greatly improving healthcare outcomes and reducing the burden on healthcare services.  And these technologies are directly available to the individual through our consumer division Randox Health, not just through GPs or hospitals.

“It is also a fact that diagnostics have historically been undervalued – in healthcare systems around the world laboratory technologies account for around 2% of overall budgets, yet 70%-80% of all healthcare decisions affecting diagnosis or treatment involve a laboratory investigation.”

Sensing the potential to improve healthcare through diagnostic innovation, Randox has invested significantly in the development of Biochip Array Technology, allowing many tests to be run simultaneously.

Dr FitzGerald continued;

“It’s taken over £285 million to see the fruition of this, the gold standard in testing. Our 300-strong team of research scientists and engineers are committed to exploring the thousands of markers of health and illness within the body and to each year unveil pioneering and innovative new tests to add to the Randox portfolio. Thanks to an annual investment of around 16% of turnover in this research and development, we have more innovations in development than any other healthcare company in the world.”

One such innovation, the concept of which is due to be revealed at the Goodwood Future Lab for the first time, is the unrivalled 32×32 Biochip. This highly anticipated testing platform will remarkably be able to provide patients with 1024 key pieces of information about their current and future health.  Combined with advanced algorithms, the effect will be truly revolutionary.

Dr FitzGerald added;

“The 32×32 Biochip is key to unlocking true personalised medicine. Ultimately it acts as a roadmap of your health by predicting the health conditions of which you are personally at risk in the future. By taking preventive action you will be empowered to live healthier for longer. It’s the world’s first technology of its kind, capable of extending your life.”

The Randox Health Mobile Clinic, in which the public can directly access Randox technologies in the form of the world’s most comprehensive health check, will be at the Goodwood Hotel on Tuesday 17^th and Wednesday 18^th July.  Those wishing to book can call 0800 2545 130 or can find out more by visiting the Randox Health website or downloading the app.

For further information please contact Randox PR by email: randoxpr@randox.com or by phoning 07980 738 120